General discussion, page-6380

Good find Khool.

Also remember the ann that said we are expanding to UWA, as well as our existing trial at the Alfred.

The team wouldnt be doing this if there wasn't any sign that the drugs were working, keep in mind that we have had patients enrolled quite a while ago.

Also in my view, why this is taking so long. Check out the key inclusion and exclusion criteria. That's a lot.

From my understanding there has been a lot of interest in our trials, the team is making sure that for our first ever pivotal human trial it's done right.

And look, to be honest it is a Phase 2B human trial. Whether the stock flip flops from 20c to 30c on the lead up to the NASDAQ is while important, not terribly a big deal in the grand scheme of things. If these results dropped tonight we would be at 40-50c in a heartbeat, and that's my view on an ASX response.

A NASDAQ response to the same would put us much higher, they seem to value biotech a lot more than we do.